Cogent Biosciences(COGT)

12.85 0.25 1.9841%

今开:12.32昨收:12.6
最高:13.0 最低:12.32
涨停价:0.0跌停价:0.0
总市值:8.98130627E8

Cogent Biosciences的热门评论

Cogent Biosciences(COGT)2020-12-01 06:30

$Cogent Biosciences(COGT)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-20-305790 Act: 33 Size: 926 KB 网页链接查看全文

Cogent Biosciences(COGT)2020-11-20 03:00

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001214659-20-009754 Act: 34 Size: 137 KB 网页链接查看全文

Cogent Biosciences(COGT)2020-11-20 05:18

$Cogent Biosciences(COGT)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-20-000653 Act: 34 Size: 86 KB 网页链接查看全文

Cogent Biosciences(COGT)2020-11-10 06:18

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-20-052593 Act: 34 Size: 7 MB 网页链接查看全文

Cogent Biosciences(COGT)2020-11-09 20:36

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02, 3.03, 5.03, 5.07, and 9.01 Accession Number: 0001193125-20-288493 Act: 34 Size: 128 KB 网页链接查看全文

Cogent Biosciences(COGT)2020-11-06 06:06

$Cogent Biosciences(COGT)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-20-286975 Act: 33 Size: 74 KB 网页链接查看全文

Cogent Biosciences(COGT)2020-10-24 04:18

$Cogent Biosciences(COGT)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-20-275468 Act: 34 Size: 29 KB 网页链接查看全文

Cogent Biosciences(COGT)2020-10-28 04:18

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-055909 Size: 5 KB 网页链接查看全文

Cogent Biosciences(COGT)2020-10-28 04:12

$Cogent Biosciences(COGT)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-20-055908 Size: 6 KB 网页链接查看全文

Cogent Biosciences(COGT)2020-10-26 19:18

$Cogent Biosciences(COGT)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001193125-20-276049 Act: 34 Size: 187 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14

Cogent Biosciences的最新评论

季度财报

Cogent Biosciences(COGT)11-14 20:33

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-024685 Act: 34 Size: 7 MB 网页链接查看全文

当期报告

Cogent Biosciences(COGT)11-14 20:21

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-024675 Act: 34 Size: 535 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)10-05 04:42

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032672 Size: 5 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)10-05 04:37

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032661 Size: 5 KB 网页链接查看全文

超过5%股东持股披露

Cogent Biosciences(COGT)09-07 04:36

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-097869 Act: 34 Size: 75 KB 网页链接查看全文

季度财报

Cogent Biosciences(COGT)08-09 19:42

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-015760 Act: 34 Size: 6 MB 网页链接查看全文

当期报告

Cogent Biosciences(COGT)08-09 19:21

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-015744 Act: 34 Size: 489 KB 网页链接查看全文

超过5%股东持股披露

Cogent Biosciences(COGT)07-09 05:06

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-010347 Act: 34 Size: 12 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)07-06 01:57

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024929 Size: 5 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)07-06 01:57

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024930 Size: 5 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14

Cogent Biosciences的新闻

Cogent Biosciences(COGT)宣布发行1.25亿美元的普通股

Cogent Biosciences(COGT)宣布已开始承销公开发行1.25亿美元的普通股。Cogent打算将此次发行的净收益用于与bezuclastinib和其他候选产品相关的开发、监管和商业准备活动,以及营运资金和一般公司用途。Jefferies、Piper Sandler& Co.和Gugge... 网页链接

Cogent Biosciences的公告

季度财报

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-024685 Act: 34 Size: 7 MB 网页链接

当期报告

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-024675 Act: 34 Size: 535 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032672 Size: 5 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032661 Size: 5 KB 网页链接

超过5%股东持股披露

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-097869 Act: 34 Size: 75 KB 网页链接

季度财报

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-015760 Act: 34 Size: 6 MB 网页链接

当期报告

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-015744 Act: 34 Size: 489 KB 网页链接

超过5%股东持股披露

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-010347 Act: 34 Size: 12 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024929 Size: 5 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024930 Size: 5 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20